Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred stock
8.625% Series A Cumulative, Perpetual Preferred Stock
Preferred stock
Convertible preferred stock.
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019   $ 6 $ 73 $ 1,238,299 $ (1,194,384) $ 43,988
Balance (in shares) at Dec. 31, 2019     9,759,000      
Increase (Decrease) in Stockholders' Equity            
Exercise of stock options (in shares)           0
Issuance of common stock related to 401(k) contribution       88   $ 88
Issuance of common stock related to 401(k) contribution (in shares)     3,000      
Stock-based compensation expense       1,788   1,788
Disgorgement of stockholder's short-swing profits       13   13
Net (loss) income         (4,758) (4,758)
Balance at Mar. 31, 2020   6 $ 73 1,240,188 (1,199,142) 41,119
Balance (in shares) at Mar. 31, 2020     9,762,000      
Balance at Dec. 31, 2020 $ 49 5 $ 84 1,267,377 (1,181,086) 86,424
Balance (in shares) at Dec. 31, 2020 984,000   11,229,000      
Increase (Decrease) in Stockholders' Equity            
Exercise of stock options       388   $ 388
Exercise of stock options (in shares)     24,000     24,193
Exercise of common stock warrants (in shares)     5,000      
Issuance of common stock related to 401(k) contribution       90   $ 90
Issuance of common stock related to 401(k) contribution (in shares)     2,000      
Stock-based compensation expense       2,898   2,898
Preferred stock dividends       (707)   (707)
Net (loss) income         (7,373) (7,373)
Balance at Mar. 31, 2021 $ 49 $ 5 $ 84 $ 1,270,046 $ (1,188,459) $ 81,720
Balance (in shares) at Mar. 31, 2021 984,000   11,260,000